Hyep Ivan
Chief Financial Officer · 31 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Sale | 22,757 | $28.60 | $650,895.71 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Sale | 4,413 | $29.82 | $131,615.96 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Option exercise | 12,500 | $3.79 | $47,372.50 | filing |
| 2026-07-08 | BCAX | Bicara Therapeutics Inc. | Sale | 830 | $30.31 | $25,160.29 | filing |
| 2026-05-21 | BCAX | Bicara Therapeutics Inc. | Sale | 9,200 | $20.42 | $187,883.32 | filing |
| 2026-05-21 | BCAX | Bicara Therapeutics Inc. | Option exercise | 9,200 | $3.79 | $34,866.16 | filing |
| 2026-04-21 | BCAX | Bicara Therapeutics Inc. | Sale | 9,200 | $23.00 | $211,613.80 | filing |
| 2026-04-21 | BCAX | Bicara Therapeutics Inc. | Option exercise | 9,200 | $3.79 | $34,866.16 | filing |
| 2026-03-23 | BCAX | Bicara Therapeutics Inc. | Sale | 9,200 | $18.52 | $170,348.12 | filing |
| 2026-03-23 | BCAX | Bicara Therapeutics Inc. | Option exercise | 9,200 | $3.79 | $34,866.16 | filing |
| 2026-03-04 | BCAX | Bicara Therapeutics Inc. | Sale | 2,963 | $18.25 | $54,061.71 | filing |
| 2026-03-04 | BCAX | Bicara Therapeutics Inc. | Option exercise | 2,963 | $3.79 | $11,229.18 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Sale | 13,555 | $18.22 | $246,909.75 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Option exercise | 7,318 | $3.79 | $27,733.76 | filing |
| 2026-03-03 | BCAX | Bicara Therapeutics Inc. | Option exercise | 6,237 | $3.79 | $23,636.98 | filing |
| 2026-01-22 | BCAX | Bicara Therapeutics Inc. | Sale | 1,882 | $18.15 | $34,162.44 | filing |
| 2026-01-22 | BCAX | Bicara Therapeutics Inc. | Option exercise | 1,882 | $3.79 | $7,132.40 | filing |
| 2025-12-22 | BCAX | Bicara Therapeutics Inc. | Sale | 9,200 | $18.31 | $168,491.56 | filing |
| 2025-12-22 | BCAX | Bicara Therapeutics Inc. | Option exercise | 9,200 | $3.79 | $34,866.16 | filing |
| 2025-11-24 | BCAX | Bicara Therapeutics Inc. | Sale | 17,795 | $18.55 | $330,093.69 | filing |
| 2025-11-24 | BCAX | Bicara Therapeutics Inc. | Option exercise | 17,795 | $3.79 | $67,439.49 | filing |
| 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Sale | 605 | $18.15 | $10,980.75 | filing |
| 2025-11-21 | BCAX | Bicara Therapeutics Inc. | Option exercise | 605 | $3.79 | $2,292.83 | filing |
| 2025-10-09 | BCAX | Bicara Therapeutics Inc. | Sale | 6,415 | $18.23 | $116,931.34 | filing |
| 2025-10-09 | BCAX | Bicara Therapeutics Inc. | Option exercise | 6,415 | $3.79 | $24,311.57 | filing |
| 2025-10-08 | BCAX | Bicara Therapeutics Inc. | Sale | 5,627 | $18.21 | $102,456.42 | filing |
| 2025-10-08 | BCAX | Bicara Therapeutics Inc. | Option exercise | 5,627 | $3.79 | $21,325.20 | filing |
| 2025-10-07 | BCAX | Bicara Therapeutics Inc. | Sale | 18,244 | $18.22 | $332,385.61 | filing |
| 2025-10-07 | BCAX | Bicara Therapeutics Inc. | Option exercise | 18,244 | $3.79 | $69,141.11 | filing |
| 2025-10-06 | BCAX | Bicara Therapeutics Inc. | Sale | 6,514 | $18.17 | $118,356.12 | filing |
| 2025-10-06 | BCAX | Bicara Therapeutics Inc. | Option exercise | 6,514 | $3.79 | $24,686.76 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.